BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 247 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $378,000 | -59.5% | 2,500 | -60.9% | 0.04% | -57.0% |
| Q2 2022 | $933,000 | -22.8% | 6,400 | -37.3% | 0.09% | -9.5% |
| Q1 2022 | $1,209,000 | -15.2% | 10,200 | -1.4% | 0.10% | -14.4% |
| Q4 2021 | $1,426,000 | -2.7% | 10,350 | -1.9% | 0.11% | -9.8% |
| Q3 2021 | $1,466,000 | +27.9% | 10,550 | -10.6% | 0.12% | +35.2% |
| Q2 2021 | $1,146,000 | +74.7% | 11,800 | +22.9% | 0.09% | +59.6% |
| Q1 2021 | $656,000 | +50.1% | 9,600 | +88.2% | 0.06% | +35.7% |
| Q4 2020 | $437,000 | +113.2% | 5,100 | +82.1% | 0.04% | +68.0% |
| Q2 2020 | $205,000 | – | 2,800 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $107,867,000 | 52.60% |
| Knoll Capital Management, LLC | 856,844 | $83,182,000 | 43.44% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,082,555 | $202,174,000 | 27.86% |
| ARS Investment Partners, LLC | 558,286 | $54,198,000 | 5.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $17,113,000 | 4.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 401,006 | $38,930,000 | 4.51% |
| Eventide Asset Management | 1,990,797 | $193,267,000 | 2.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 56,626 | $5,497,000 | 2.45% |
| Avidity Partners Management LP | 882,500 | $85,673,000 | 2.32% |
| Nicholas Investment Partners, LP | 363,708 | $35,309,000 | 2.22% |